We kindly inform you that on March 1, 2024 the company Warszawskie Zakłady Farmaceutyczne Polfa Spółka Akcyjna with registered office in Warsaw, Karolkowa 22/24 street (“Polfa Warszawa”) merged with  Zakłady Farmaceutyczne “POLPHARMA” Spółka Akcyjna with registered office in Starogard Gdański, Pelplińska 19 street (“Polpharma”).

The business combination fulfils one of the transformation objectives, which is to simplify management structures and processes in order to increase operational efficiency.

As a result of the business combination, Polpharma, effective from the business combination date, i.e. March 1, 2024, assumed all the rights and obligations of Polfa Warszawa.

Effective from the business combination date, Polpharma became a party to all the contracts without the need to amend them by way of amendments and is required to meet all the existing obligations of Polfa Warszawa. The address details of Polpharma remain unchanged.

Notice about the change of the Personal Data Administrator

Reporting side effects of Polfa Warsaw products

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.